2026-00633Rule

DEA Bans 4-Fluoroamphetamine as Schedule I Controlled Substance

Published Date: 1/15/2026

Rule

Summary

Starting February 17, 2026, 4-fluoroamphetamine (4-FA) is officially a Schedule I drug, meaning it’s now tightly controlled like other dangerous substances. This change affects anyone who makes, sells, studies, or even possesses 4-FA, bringing serious legal rules and penalties. The move helps the U.S. follow international drug laws and keeps communities safer.

Analyzed Economic Effects

5 provisions identified: 0 benefits, 5 costs, 0 mixed.

4‑FA Becomes Schedule I Drug

Starting February 17, 2026, 4‑fluoroamphetamine (4‑FA) is placed in Schedule I of the Controlled Substances Act. Anyone who makes, distributes, imports, exports, possesses, or otherwise handles 4‑FA will be subject to the regulatory controls and administrative, civil, and criminal sanctions that apply to Schedule I substances.

DEA Registration Required to Handle 4‑FA

Anyone who handles (manufactures, distributes, reverse distributes, imports, exports, engages in research, conducts instructional activities or chemical analysis with, or possesses) 4‑FA must register with the Drug Enforcement Administration under 21 U.S.C. 822, 823, 957, and 958 and in accordance with 21 CFR parts 1301 and 1312. Persons currently handling 4‑FA who are not registered must apply for registration and may not continue to handle 4‑FA unless DEA approves their application.

Research on 4‑FA Requires DEA Permission

Placement of 4‑FA in Schedule I does not ban research but requires those wishing to conduct research on 4‑FA to seek DEA permission and appropriate registration. The rule cites 21 U.S.C. provisions and provides a DEA webform for researchers to request authorization.

Surrender or Transfer Stocks Before Effective Date

If a person is unwilling or unable to obtain a Schedule I registration, they must surrender or transfer all quantities of 4‑FA to a DEA‑registered person before the effective date of February 17, 2026, and dispose of 4‑FA in accordance with 21 CFR part 1317 and other applicable laws. Retail sales of Schedule I substances to the general public are not allowed under the CSA.

New Handling Controls: Security, Records, Inventories

As a Schedule I substance, 4‑FA is subject to Schedule I security requirements, labeling and packaging rules, manufacturing quotas, initial and biennial inventories (initial inventory on the date the registrant first handles controlled substances; inventory thereafter every two years), recordkeeping and reporting, order form requirements, and import/export controls as specified by the CSA and 21 CFR parts cited in the rule.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Rule Effective
1/15/2026
2/17/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in